These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37427981)

  • 1. Abnormal electrocardiogram and poor prognosis in heart failure with preserved ejection fraction.
    He T; Liu C; Liang W
    Postgrad Med J; 2023 Oct; 99(1177):1154-1159. PubMed ID: 37427981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of the electrocardiogram in stable outpatients with type 2 diabetes.
    Gregers MCT; Schou M; Jensen MT; Jensen J; Petrie MC; Vilsbøll T; Goetze JP; Rossing P; Jørgensen PG
    Scand Cardiovasc J; 2022 Dec; 56(1):256-263. PubMed ID: 35811473
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction.
    Selvaraj S; Ilkhanoff L; Burke MA; Freed BH; Lang RM; Martinez EE; Shah SJ
    J Am Soc Echocardiogr; 2014 Jan; 27(1):74-82.e2. PubMed ID: 24075945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of heart rate changes during hospitalization on outcome in heart failure with preserved ejection fraction.
    Liu D; Cui X; Xu Y; Xu L; Xie Z; Yuan S; Wang P; Wang Y; Qian S; Gong H; Nordbeck P; Yang J; Zhou J; Ge J; Sun A
    ESC Heart Fail; 2024 Mar; ():. PubMed ID: 38514992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
    Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
    JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study.
    Vazir A; Claggett B; Pitt B; Anand I; Sweitzer N; Fang J; Fleg J; Rouleau J; Shah S; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2017 Nov; 5(11):782-791. PubMed ID: 29032132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
    Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
    JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the 12-lead surface electrocardiogram in sarcomeric hypertrophic cardiomyopathy: data from the REMY French register.
    Ledieu N; Larnier L; Auffret V; Marie C; Fargeau D; Donal E; Mirabel M; Jeunemaitre X; Puscas T; Marijon E; Reynaud A; Ritter P; Lafitte S; Mabo P; Réant P; Daubert C; Hagège AA;
    Europace; 2020 Jan; 22(1):139-148. PubMed ID: 31603495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose co-transporter 2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an updated systematic review and meta-analysis.
    Wang Y; Gao T; Meng C; Li S; Bi L; Geng Y; Zhang P
    Eur J Med Res; 2022 Dec; 27(1):314. PubMed ID: 36581880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
    Cikes M; Claggett B; Shah AM; Desai AS; Lewis EF; Shah SJ; Anand IS; O'Meara E; Rouleau JL; Sweitzer NK; Fang JC; Saksena S; Pitt B; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas.
    Bajaj NS; Kalra R; Gupta K; Aryal S; Rajapreyar I; Lloyd SG; McConathy J; Shah SJ; Prabhu SD
    ESC Heart Fail; 2020 Aug; 7(4):1676-1687. PubMed ID: 32424980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
    O'Neal WT; Mazur M; Bertoni AG; Bluemke DA; Al-Mallah MH; Lima JAC; Kitzman D; Soliman EZ
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28546456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
    Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
    ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
    Saito Y; Obokata M; Harada T; Kagami K; Wada N; Okumura Y; Ishii H
    Eur J Prev Cardiol; 2023 Jul; 30(9):902-911. PubMed ID: 37094815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Shen L; Jhund PS; Docherty KF; Petrie MC; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Swedberg K; Zile MR; McMurray JJV
    JACC Heart Fail; 2019 May; 7(5):418-427. PubMed ID: 30981744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
    Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD
    J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.